# Kestra Medical Technologies, Ltd. (KMTS) FY2026 Q1 Statement of Cash Flows

- Company: Kestra Medical Technologies, Ltd. (KMTS)
- Period: 2026-05-01 to 2026-07-31
- Filing: Q1 FY2026 10-Q, filed 2026-09-14, accession number 0001193125-26-390766
- Page: https://plicit.ai/financials/kmts/fy2026-q1-cash-flow
- Chart image: https://plicit.ai/charts/kmts-fy2026-q1-cash-flow-sankey.png

## Chart details

Cash flows for May 1, 2026 through Jul 31, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Apr 30, 2026. Ending cash: Jul 31, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Apr 30, 2026**: 100,044,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: negative 32,295,000 US dollars. Net cash used.
- **Net loss**: negative 44,087,000 US dollars
- **Depreciation and amortization**: 2,664,000 US dollars
- **Loss on disposal of property and equipment**: 292,000 US dollars
- **Reserve for equipment and supplies**: 1,464,000 US dollars
- **(Recovery) provision for uncollectible accounts receivable**: negative 817,000 US dollars
- **Amortization (accretion) of premiums (discounts) on securities, net**: negative 890,000 US dollars
- **Loss on extinguishment of debt**: 6,304,000 US dollars
- **Amortization of debt discounts and issuance costs**: 408,000 US dollars
- **Share-based compensation expense**: 9,517,000 US dollars
- **Non-cash lease expense**: 103,000 US dollars
- **Change in fair value of warrant liabilities**: 251,000 US dollars
- **Disposable medical equipment supplies**: negative 908,000 US dollars
- **Prepaid expenses and other current assets**: 246,000 US dollars
- **Accounts receivable**: negative 48,000 US dollars
- **Accounts payable**: negative 1,879,000 US dollars
- **Accrued liabilities**: negative 4,727,000 US dollars
- **Operating lease liabilities**: negative 190,000 US dollars
- **Other long-term assets**: 2,000 US dollars
- **Investing activities**: negative 21,352,000 US dollars. Net cash used.
- **Purchases of property and equipment**: negative 8,335,000 US dollars
- **Deposits for medical rental equipment**: 0 US dollars
- **Refund of deposits for medical rental equipment**: 0 US dollars
- **Purchase of marketable securities**: negative 13,017,000 US dollars
- **Financing activities**: 22,495,000 US dollars. Net cash provided.
- **Proceeds from issuance of long-term debt**: 75,000,000 US dollars
- **Payment of debt issuance costs**: negative 3,193,000 US dollars
- **Repayment of long-term debt**: negative 46,395,000 US dollars
- **Payment of early termination fee on debt repayment**: negative 3,758,000 US dollars
- **Proceeds from stock option exercises**: 1,140,000 US dollars
- **Proceeds from employee stock purchase plan**: 1,298,000 US dollars
- **Tax withholdings on restricted stock unit vesting**: negative 1,010,000 US dollars
- **Deemed dividend for payments to third party on behalf of shareholder**: negative 172,000 US dollars
- **Payment of equity issuance costs**: negative 415,000 US dollars
- **Operating adjustment reconciliation**: 53,546,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 77,438,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 21,352,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 0 US dollars
- **Ending cash on Jul 31, 2026**: 68,892,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 122,539,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: negative 31,152,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- **Operating cash flow**: negative 32,295,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 8,335,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: negative 40,630,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$44.09M + net operating adjustments $11.79M = operating cash −$32.30M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 32,295,000 US dollars minus 8,335,000 US dollars equals negative 40,630,000 US dollars.